RadNet, Inc. (RDNT)
NASDAQ: RDNT · Real-Time Price · USD
71.83
+1.23 (1.74%)
Oct 13, 2025, 3:55 PM EDT - Market open
RadNet Revenue
RadNet had revenue of $498.23M in the quarter ending June 30, 2025, with 8.38% growth. This brings the company's revenue in the last twelve months to $1.91B, up 11.33% year-over-year. In the year 2024, RadNet had annual revenue of $1.83B with 13.18% growth.
Revenue (ttm)
$1.91B
Revenue Growth
+11.33%
P/S Ratio
2.74
Revenue / Employee
$211,986
Employees
9,000
Market Cap
5.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.83B | 213.03M | 13.18% |
| Dec 31, 2023 | 1.62B | 186.57M | 13.05% |
| Dec 31, 2022 | 1.43B | 105.87M | 8.00% |
| Dec 31, 2021 | 1.32B | 226.08M | 20.59% |
| Dec 31, 2020 | 1.10B | -56.08M | -4.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
RDNT News
- 17 days ago - RadNet, Inc. to Present at the Jefferies Healthcare Services Conference on September 29, 2025 - GlobeNewsWire
- 4 weeks ago - RadNet, Inc. (RDNT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025 - GlobeNewsWire
- 6 weeks ago - Coulda, Woulda, Shoulda: Are These 5 Stocks Too Overvalued to Buy Now? - Kiplinger
- 2 months ago - RadNet, Inc. (RDNT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges - GlobeNewsWire
- 2 months ago - Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts - Seeking Alpha
- 2 months ago - RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call - GlobeNewsWire